nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute venous thromboembolism in patients with brain cancer: clinical course
|
Becattini, Cecilia |
|
|
7 |
6 |
p. |
artikel |
2 |
Anti-emicizumab antibodies do not cross-react with mim8 in vitro
|
Valsecchi, Carla |
|
|
7 |
6 |
p. |
artikel |
3 |
Avatrombopag for adult chronic primary immune thrombocytopenia: a randomized phase 3 trial in China
|
Mei, Heng |
|
|
7 |
6 |
p. |
artikel |
4 |
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
|
Agosti, Pasquale |
|
|
7 |
6 |
p. |
artikel |
5 |
Citrullination of α2-antiplasmin is unlikely to contribute to enhanced plasmin generation in COVID-19 pathophysiology
|
Kangro, Kadri |
|
|
7 |
6 |
p. |
artikel |
6 |
Coagulation factors II, V, VII, IX, X and XI and mortality – a cohort study
|
Yap, Eng Soo |
|
|
7 |
6 |
p. |
artikel |
7 |
Congenital thrombophilia in East-Asian venous thromboembolism population: a systematic review and meta-analysis
|
Zhu, Xi-Jie |
|
|
7 |
6 |
p. |
artikel |
8 |
Editorial Board
|
|
|
|
7 |
6 |
p. |
artikel |
9 |
Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial
|
Smilowitz, Nathaniel R. |
|
|
7 |
6 |
p. |
artikel |
10 |
Health-related quality of life is impaired in bleeding disorders of unknown cause: results from the Vienna Bleeding Biobank
|
Mehic, Dino |
|
|
7 |
6 |
p. |
artikel |
11 |
Issue Information
|
|
|
|
7 |
6 |
p. |
artikel |
12 |
Letter in response to Othman & Favaloro “Comparison of two ways of performing ristocetin-induced platelet agglutination (RIPA) mixing study for diagnosis of type 2B VWD”
|
Soleimani, Reza |
|
|
7 |
6 |
p. |
artikel |
13 |
Lipoprotein(a) and risk of cognitive impairment in Black and White Americans: the Reasons for Geographic and Racial Differences in Stroke cohort
|
Arce Rentería, Miguel |
|
|
7 |
6 |
p. |
artikel |
14 |
Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demand
|
Álvarez-Román, María-Teresa |
|
|
7 |
6 |
p. |
artikel |
15 |
Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study
|
Dobesh, Paul P. |
|
|
7 |
6 |
p. |
artikel |
16 |
Management of surgery in persons with hemophilia A receiving emicizumab prophylaxis: data from a national hemophilia treatment center
|
Cohen, Omri |
|
|
7 |
6 |
p. |
artikel |
17 |
Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay
|
Bonnez, Quintijn |
|
|
7 |
6 |
p. |
artikel |
18 |
Mim8, a novel factor VIIIa mimetic bispecific antibody, shows favorable safety and pharmacokinetics in healthy adults
|
Persson, Paula |
|
|
7 |
6 |
p. |
artikel |
19 |
Neutralizing antidrug antibody to emicizumab in patients with severe hemophilia A: Case report of a first noninhibitor patient and review of the literature
|
Kizilocak, Hande |
|
|
7 |
6 |
p. |
artikel |
20 |
New insight into the traditional model of the coagulation cascade and its regulation: illustrated review of a three-dimensional view
|
Troisi, Romualdo |
|
|
7 |
6 |
p. |
artikel |
21 |
No von Willebrand factor domains other than A1 are involved in type 2B von Willebrand disease: what the p.R924Q and p.A2178S variants teach us
|
Casonato, Alessandra |
|
|
7 |
6 |
p. |
artikel |
22 |
Overuse and underuse of thromboprophylaxis in medical inpatients
|
Kocher, Barbara |
|
|
7 |
6 |
p. |
artikel |
23 |
Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19
|
Zhang, Ziyu |
|
|
7 |
6 |
p. |
artikel |
24 |
Progestin-only contraception is first line for sickle cell disease: a comment on “Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias.”
|
Pecker, Lydia H. |
|
|
7 |
6 |
p. |
artikel |
25 |
Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults
|
Konkle, Barbara A. |
|
|
7 |
6 |
p. |
artikel |
26 |
Psychometrics of the patient-reported outcomes measurement information system measures in hemophilia: the applicability of the pediatric item banks
|
Teela, Lorynn |
|
|
7 |
6 |
p. |
artikel |
27 |
Recombinant factor IX Fc for major surgery in hemophilia B: factor IX plasma activity levels and effective hemostasis
|
Shapiro, Amy D. |
|
|
7 |
6 |
p. |
artikel |
28 |
Reply to “Comment on: A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays”
|
Colpani, Paola |
|
|
7 |
6 |
p. |
artikel |
29 |
Role of heat shock protein 47 in platelet glycoprotein VI dimerization and signaling
|
AlOuda, Sarah K. |
|
|
7 |
6 |
p. |
artikel |
30 |
Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays
|
Bouck, Emma G. |
|
|
7 |
6 |
p. |
artikel |
31 |
Thromboembolism in nephrotic syndrome: controversies and uncertainties
|
Parker, Kathrine |
|
|
7 |
6 |
p. |
artikel |
32 |
Tissue factor-heparanase complex: intracellular nonhemostatic effects
|
Ghanem, Shorook |
|
|
7 |
6 |
p. |
artikel |
33 |
T2 mapping magnetic resonance imaging of cartilage in hemophilia
|
Brakel, Benjamin A. |
|
|
7 |
6 |
p. |
artikel |
34 |
Toward non-factor therapy in hemophilia: an antithrombin insensitive Gla-domainless factor Xa as tissue factor pathway inhibitor bait
|
Dagher, Marie-Claire |
|
|
7 |
6 |
p. |
artikel |
35 |
Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach
|
Liu, Zikou |
|
|
7 |
6 |
p. |
artikel |
36 |
Venous thromboembolism prophylaxis for hospitalized adult patients: a survey of US health care providers on attitudes and practices
|
Lam, Barbara D. |
|
|
7 |
6 |
p. |
artikel |